MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 276 filers reported holding MYRIAD GENETICS INC in Q4 2014. The put-call ratio across all filers is 2.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $4,115,000 | -88.2% | 106,698 | -88.1% | 0.28% | -87.9% |
| Q2 2014 | $34,887,000 | +13.8% | 896,379 | -0.0% | 2.27% | +8.2% |
| Q1 2014 | $30,657,000 | +43.7% | 896,677 | -11.8% | 2.10% | +48.6% |
| Q4 2013 | $21,327,000 | -53.7% | 1,016,524 | -48.1% | 1.41% | -8.1% |
| Q3 2013 | $46,022,000 | +110.8% | 1,958,356 | +141.0% | 1.54% | +32.0% |
| Q2 2013 | $21,836,000 | – | 812,656 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |